T
1.26
0.10 (8.62%)
| Penutupan Terdahulu | 1.16 |
| Buka | 1.15 |
| Jumlah Dagangan | 38,436,423 |
| Purata Dagangan (3B) | 28,263,676 |
| Modal Pasaran | 1,138,140,416 |
| Harga / Jualan (P/S) | 1.32 |
| Harga / Buku (P/B) | 0.350 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 9 Jan 2025 |
| Margin Keuntungan | -26.18% |
| Margin Operasi (TTM) | -14.69% |
| EPS Cair (TTM) | -0.270 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 13.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.15% |
| Nisbah Semasa (MRQ) | 2.47 |
| Aliran Tunai Operasi (OCF TTM) | -50.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -35.79 M |
| Pulangan Atas Aset (ROA TTM) | -1.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.84% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Tilray Brands, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.13 |
|
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.67% |
| % Dimiliki oleh Institusi | 12.10% |
| Julat 52 Minggu | ||
| Median | 1.75 (38.89%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Roth MKM | 11 Oct 2024 | 1.75 (38.89%) | Pegang | 1.63 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |